This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ariamala Gopalsamy: Inventor in Cancer Research
Introduction
Ariamala Gopalsamy is an inventor based in Wilmington, Delaware, and is associated with AstraZeneca AB. His patent work concerns a potential therapeutic approach to cancer through inhibition of DNA polymerase theta, also known as Polθ or POLQ.
Latest Patents
Gopalsamy is named on one patent, titled “POLQ Inhibitors.” The patent describes compounds of Formula (I), including stereoisomers and pharmaceutically acceptable salts, as well as compositions containing those compounds. The compounds inhibit POLQ, an enzyme involved in DNA repair, and are presented as potentially useful in cancer treatment. The patent record lists 1 patent for Gopalsamy.
Career Highlights
His listed work connects medicinal chemistry and therapeutic research, focusing on compounds designed to inhibit a biological target relevant to cancer. His association with AstraZeneca AB places this invention within the pharmaceutical research and development field.
Collaborations
Gopalsamy’s listed coworker is Bernard Barlaam. Their shared professional context is associated with the POLQ inhibitor patent and its potential therapeutic applications.
Conclusion
Ariamala Gopalsamy’s patent activity highlights research into POLQ-inhibiting compounds as a possible avenue for cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile